Pfizer Must Face Trimmed Robitussin Labeling Suit

By Hannah Albarazi (November 16, 2021, 6:14 PM EST) -- Pharmaceutical giant Pfizer won the partial dismissal of a proposed class action in New York federal court Monday accusing it of misleading consumers with its "Maximum Strength" labeling of Robitussin cough syrup, but it failed to get the suit's nationwide class allegations stricken....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!